Visentin M, Lenggenhager D, Gai Z, et al. Drug-induced bile duct injury[J]. Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease, 2018, 1864:1498-1506
|
Woodhead J L, Brock W J, Roth S E, et al. Application of a mechanistic model to evaluate putative mechanisms of tolvaptan drug-induced liver injury and identify patient susceptibility factors[J]. Toxicological Sciences, 2017, 155(1):61-74
|
Hamilton L A, Collins Y A, Collins R E. Drug-induced liver injury[J]. Advanced Critical Care Nursing, 2016, 27(4):430-440
|
Zhang J, Doshi U, Suzuki A, et al. Evaluation of multiple mechanism-based toxicity endpoints in primary cultured human hepatocytes for the identification of drugs with clinical hepatotoxicity:Results from 152 marketed drugs with known liver injury profiles[J]. Chemico-Biological Interactions, 2016, 255:3-11
|
Ye H, Nelson L J, Gómez D M M, et al. Dissecting the molecular pathophysiology of drug-induced liver injury[J]. World Journal of Gastroenterology, 2018, 24:1373-1385
|
Donato M T, Gómez-Lechón M J, Tolosa L. Using high-content screening technology for studying drug-induced hepatotoxicity in preclinical studies[J]. Expert Opinion on Drug Discovery, 2017, 12(2):201-211
|
Mandavilli B S, Aggeler R J, Chambers K M. Tools to measure cell health and cytotoxicity using high content imaging and analysis[J]. Methods in Molecular Biology, 2018, 1683:33-46
|
Tolosa L, Gómez-L M J, Donato M T. High-content screening technology for studying drug-induced hepatotoxicity in cell models[J]. Archives of Toxicology, 2015, 89(7):1007-1022
|
Zhang J, Wang S, Xu L, et al. Multiple perspectives of qingkailing injection-fraction-single compound in revealing the hepatotoxicity of baicalin and hyodeoxycholic acid[J]. Journal of Ethnopharmacology, 2017, 215:147-155
|
Wu Y, Geng X C, Wang J F, et al. The HepaRG cell line, a superior in vitro model to L-02, HepG2 and hiHeps cell lines for assessing drug-induced liver injury[J]. Cell Biology and Toxicology, 2016, 32(1):37-59
|
Thakkar S, Tong W, Chen M, et al. The Liver Toxicity Knowledge Base (LKTB) and drug-induced liver injury (DILI) classification for assessment of human liver injury[J]. Expert Review of Gastroenterology & Hepatology, 2017, 12(1):31-38
|
Yu K, Zhang J, Chen M, et al. Mining hidden knowledge for drug safety assessment:Topic modeling of LiverTox as a case study[J]. BMC Bioinformatics, 2014, 15(Suppl 17):S6
|
Li X, Li X Y, Huang N, et al. A comprehensive review and perspectives on pharmacology and toxicology of saikosaponins[J]. Phytomedicine, 2018, 50:73-87
|
Moo L B, Cheul L W, Young J J, et al. Clinical features of drug-induced liver injury according to etiology[J]. Journal of Korean Medical Science, 2015, 30(12):1815-1820
|